sentence: Nowadays there are two EGFR targeting strategies used in clinical practice : monoclonal antibodies directed at the extracellular domain of the receptor and small molecule , and ATP tyrosine kinase inhibitors.4 ,5 The use of both modalities in the treatment of SCCHN is currently under investigation .